Form 4 for QTRX Quanterix Corp
Accepted 2021-11-08 00:00:00 ET · period of report 2021-11-04 · accession 0001562180-21-006883 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-11-08 | 2021-11-04+ | QTRX | Mattoon Dawn | SVP, Diagnostics | S - Sale+OE | $57.28 | -8,536 | 38.9K | -18% | -$488.9K |
| D | 2021-11-08 | 2021-11-05 | QTRX | Mattoon Dawn | SVP, Diagnostics | M - OptEx | $19.12 | +10.7K | 47.2K | +29% | +$204.9K |
| D | 2021-11-08 | 2021-11-05 | QTRX | Mattoon Dawn | SVP, Diagnostics | M - OptEx | $0.00 | -10.7K | 10.6K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-05 | S | D | 200 | $58.39 | 38,697 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $58.35 to $58.435.The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. (F2) Includes 13,966 restricted stock units. |
| 2 | Common | Common Stock | 2021-11-05 | M | A | 10,718 | $19.12 | 47,232 | D | — | — | (F2) Includes 13,966 restricted stock units. |
| 3 | Common | Common Stock | 2021-11-04 | S | D | 1 | $57.00 | 36,514 | D | — | — | |
| 4 | Common | Common Stock | 2021-11-05 | S | D | 8,335 | $57.25 | 38,897 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $57.00 to $57.975. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. (F2) Includes 13,966 restricted stock units. |
| 5 | Derivative | Stock Option (right to buy) | 2021-11-05 | M | D | 10,718 | $0.00 | 10,557 | D | $19.12 · — to 2028-05-10 | 10,718 Common Stock | (F5) The option vests as to 25% of the shares on May 10, 2019 and vests as to an additional 2.083% of the shares per month for 36 months thereafter. |